ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: INFO14

The Hepatorenal Fibrocystic Disease Core Center

Session Information

  • Informational Posters
    October 25, 2018 | Location: Exhibit Hall, San Diego Convention Center
    Abstract Time: 10:00 AM - 12:00 PM


  • No subcategory defined


  • Yoder, Bradley K., University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Guay-Woodford, Lisa M., Children's National Health System, Washington, District of Columbia, United States
  • Bell, P. Darwin, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Lipschutz, Joshua H., Medical University of South Carolina, Charleston, South Carolina, United States
  • Mrug, Michal, University of Alabama at Birmingham, Birmingham, Alabama, United States

The Hepatorenal Fibrocystic Disease Core Center (HRFDCC) is an established interdisciplinary Center with a unique focus on Autosomal Recessive Polycystic Kidney Disease (ARPKD) and other single gene recessive HRFD disorders (NPHP, MKS, BBS, JBTS, OFD, etc.). The Center is multi-institutional with Cores located in three medical Universities in the Southeastern US. This multi-institutional format provides opportunities for integrating the unique research and clinical expertise that are housed in each of these institutions and to expand institutional support for Center’s activities. Further, the HRFDCC coordinates training and research opportunities with multiple NIH and University Centers including the UAB/UCSD O’Brien Center, UAB Nephrology Research and Training Center, and the Clinical and Translational Science Award (CTSA) programs at each institution. This allows the Center to expand activities far beyond that possible with only the P30 support. The overarching goals of the HRFDCC are: 1) to attract and support new scientific expertise and research into causes of HRFDs; 2); to facilitate the use of scientifically rigorous, state-of-the-art methodologies in a cost-effective manner to address HRFD pathogenesis; 3) to expand capabilities and specificity of diagnostic tools associated with HRFDs; and 4) to promote testing and development of efficacious treatments for HRFDs.